New Era in Radiation Oncology for Lung Cancer: Recognizing the Importance of Cardiac Irradiation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary.International journal of radiation oncology, biology, physics · 2025
   Guideline
2. Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma.International journal of radiation oncology, biology, physics · 2019
   Trial
3. Quantitative Assessment of 3D Dose Rate for Proton Pencil Beam Scanning FLASH Radiotherapy and Its Application for Lung Hypofractionation Treatment Planning.Cancers · 2021
   Article
4. Cardiovascular Complications Associated with Contemporary Lung Cancer Treatments.Current treatment options in oncology · 2021
   Review
5. The impact of baseline shifts towards the heart after image guidance on survival in lung SABR patients.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2020
   Article
6. Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2020
   Article
7. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.Annals of oncology : official journal of the European Society for Medical Oncology · 2020
   Article
8. Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy.Journal of thoracic disease · 2018
   Review
9. Proton therapy for small cell lung cancer.Translational lung cancer research · 2018
   Review
10. Cardiac radiation dose distribution, cardiac events and mortality in early-stage lung cancer treated with stereotactic body radiation therapy (SBRT).Journal of thoracic disease · 2018
    Article
11. Proton Beam Therapy for Bronchogenic Adenoid Cystic Carcinoma: Dosimetry, Toxicities, and Outcomes.International journal of particle therapy · 2018
    Article
12. Breaking the dose ceiling: proton therapy for locally advanced non-small cell lung cancer.Journal of thoracic disease · 2018
    Article
13. Acute and Late Toxicities of Concurrent Chemoradiotherapy for Locally-Advanced Non-Small Cell Lung Cancer.Cancers · 2017
    Review

Corrections and comments

• Comment on
  Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as